Summary: A newly developed lab-designed molecule, JM2, may offer a promising therapy to combat glioblastoma recurrence by targeting the tumors most resilient cells. Researchers discovered that gliobl… [+8092 chars]
.png)
Your trusted source for breaking news, in-depth analysis, and comprehensive coverage of today's most important stories.
Get daily updates on breaking news, exclusive interviews, and special features delivered to your inbox.
Have a news tip or want to get in touch with our editorial team? We're here to help.
Austin, Texas, USA